HackingHealthcareFinancial ServicesHealthcareData ExfiltratedCustomer Data InvolvedIdentity (basic)Health (basic)Financial accountLowContained

TAKEDA PHARMACEUTICALS U.S.A., INC.

bd_e062f954f4eceb7e · schema v1 · pii pii-v1

Severity

Low

Discovered

—

Filed

May 31, 2024

To disclose

—

Affected

Not disclosed

Linked

4 filings

Confidence

67%

Full breach record for TAKEDA PHARMACEUTICALS U.S.A., INC. →3 incidents on file

Cencora, Inc. experienced a data breach on February 21, 2024, resulting in the exfiltration of personal information including names, addresses, dates of birth, health diagnoses, and medications. Lash Group, a partner, notified affected consumers on May 31, 2024. Cencora engaged law enforcement and cybersecurity experts, and offered 24 months of credit monitoring.

J jump to incidentP pin to compareR raw source

Incident timeline — partial

? — ?

Breach window unknown

May 31, 2024

Filed

No interval is drawn: no breach start or discovery date is on record for this filing.

This filing is one of 4 filings about the same incident.View merged incident

Linked disclosures

Why this link?

Regulatory filings (3) · sorted by filing gap

Montana State AGbd_5e917fa48fdb11b82024-05-31Verified
Washington State AGbd_8619ca12c3305b702024-05-31Verified
California State AGbd_a1233d4e57e901f02024-05-31Verified

Name: Pro Lash
norm: pro lash
Domain: prolash.com

Name: TAKEDA PHARMACEUTICALS U.S.A., INC.
norm: takeda pharmaceuticals usa
Industry: HealthcarellmFinancial Servicesllm

Discovered: —
Materiality determined: —
Notification sent: May 31, 2024
Affected individuals: Not disclosed
Data types: Identity (basic)Health (basic)Financial account
Attack vector: Unauthorized Access
MITRE ATT&CK: T1041 Exfiltration Over C2 ChannelT1119 Automated Collection
Threat actor: ExternalFinancial
Third party: via Cencora, Inc.

During the incident: Launched an investigation with the assistance of cybersecurity experts, law enforcement, and outside lawyers
Providing access to Experian IdentityWorks credit monitoring and remediation services for 24 months at no charge
Changes made: Working with cybersecurity experts to reinforce systems and information security protocols
Source: Quoted from the filing itself, not independently verified.

Compliance flags: — (clock not assessable for this source)

Status: No extraction artifact recorded for this disclosure.

Filing propagation · 4 filings · 4 states

View merged incident ↗

Montana State AGMay 31 · first

Washington State AGMay 31 · first

California State AGMay 31 · first

Vermont State AGMay 31 · first · this page

Evidence ladder

Leak-site claim

Attacker assertion only. Establishes: claim date, group, alleged victim.

Press / market report

Unlocks: incident narrative, operational impact. Still no compliance clock.

State AG / regulator filingThis record

Unlocks: discovery date, data types, affected count, compliance clock.

SEC 8-K / victim statement

Unlocks: materiality, stated response, full audit trail. Ceiling removed.

Source URL: https://ago.vermont.gov/document/2024-05-31-takeda-pharmaceuticals-usa-data-breach-notice-consumers
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
Filed at: May 31, 2024
Raw hash: bb99a274a528e557c64b85e0b433be31df6fc41b19f309facaf2ea2f01f34f41

Linked disclosures

Regulatory filings (3) · sorted by filing gap

Reporting entityPro Lash

Victim entityTAKEDA PHARMACEUTICALS U.S.A., INC.

IncidentUnauthorized Access

Stated responseLaunched an investigation with the assistance of cybersecurity experts, law enforcement, and outside lawyers

Complianceclock not assessable

Extraction provenanceno artifact recorded

Source provenanceago.vermont.gov